CHRS - Coherus Biosciences Inc
IEX Last Trade
1.39
-0.030 -2.158%
Share volume: 593,447
Last Updated: Fri 30 Aug 2024 09:57:45 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$1.42
-0.03
-2.11%
Summary score
16%
Profitability
25%
Dept financing
25%
Liquidity
31%
Performance
0%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-36.98%
Return on assets
-7.25%
Return on sales
-73.1%
Return on invested capital
52.32%
Total debt ratio
102.1%
Debt ratio change over timeo
-0.24%
Current Ratio
2.97%
Quick Ratio
2.74%
Cash Position Ratio
1.67%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-7.58%
Return on assets
-7.34%
Return on sales
-58.06%
Return on invested capital
27.25%
Total debt ratio
125.39%
Debt ratio change over timeo
-0.2%
Current Ratio
1.68%
Quick Ratio
1.44%
Cash Position Ratio
0.56%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-125.7%
Return on assets
-5.57%
Return on sales
-55.18%
Return on invested capital
-25.58%
Total debt ratio
110.72%
Debt ratio change over time
1.47%
Current Ratio
1.17%
Quick Ratio
1.05%
Cash Position Ratio
0.48%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-259.62%
Return on assets
-116.39%
Return on sales
-243.71%
Return on invested capital
-8.33%
Total debt ratio
-23.87%
Debt ratio change over time
-0.24%
Current Ratio
-0.71%
Quick Ratio
-0.84%
Cash Position Ratio
-0.82%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | CHRS | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -36.98% | 13.79% | 34.47% | 7.43% |
| Return on assets | -7.25% | 2.76% | 3.15% | 5.62% |
| Return on sales | -73.1% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | 52.32% | 2.36% | 5.39% | 19.77% |
| Profitability | 25% | 41% | 62% | 65% |
| Total debt ratio | 102.1% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -0.24% | 308.97% | -6.99% | 1.18% |
| Dept financing | 25% | 47% | 22% | 7% |
| Current Ratio | 1.68% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 1.44% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 0.56% | 0.36% | 1.28% | 2.93% |
| Liquididy | 55% | 14% | 33% | 75% |
| Short-term ratios | CHRS | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -7.58% | 13.77% | 13.25% | 3.8% |
| Return on assets | -7.34% | 2.43% | 1.89% | 3.09% |
| Return on sales | -58.06% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | 27.25% | 2.14% | 3.39% | 9.18% |
| Profitability | 25% | 67% | 62% | 65% |
| Total debt ratio | 125.39% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -0.2% | 46.38% | -72.08% | 1.51% |
| Dept financing | 25% | 43% | 19% | 5% |
| Current Ratio | 1.68% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 1.44% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 0.56% | 0.36% | 1.28% | 2.93% |
| Liquididy | 20% | 12% | 31% | 75% |